EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Aspire Biopharma Holdings, Inc. (ASBP) EBIT Margin data is not available.
| Income Statement Financials | |
$0.00M |
|
$-1.85M |
|
$0.00M |
|
$0.00M |
|
$1.15M |
|
$-1.15M |
|
$-0.70M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.15M |
|
$-1.15M |
|
1.24M |
|
1.24M |
|
$-1.60 |
|
$-1.60 |
|
| Balance Sheet Financials | |
$2.40M |
|
-- |
|
-- |
|
$2.40M |
|
$13.86M |
|
-- |
|
$0.01M |
|
$13.87M |
|
$-11.47M |
|
$-11.47M |
|
$-11.47M |
|
1.24M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
-- |
|
$5.94M |
|
$0.00M |
|
$1.95M |
|
$1.94M |
|
$14.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.75 |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
-- |
|
-- |
|
16.14% |
|
16.14% |
|
-77.00% |
|
16.14% |
|
$-9.26 |
|
$-3.23 |
|
$-3.23 |
|